FDA's Risk Evaluation Guidance Brings Clarity, Not Solutions
This April, the U.S. Food and Drug Administration issued final guidance clarifying how the FDA applies the factors in section 505-1 of the Federal Food, Drug and Cosmetic Act[1] to determine...To view the full article, register now.
Already a subscriber? Click here to view full article